Clinical Trial Update: A Broad Multi-histology Phase II Study of the Multi-Kinase Inhibitor R935788 (Fostamatinib Disodium) in Advanced Colorectal, Non-small Cell Lung, Head and Neck Hepatocellular and Renal Cell Carcinomas, and Pheochromocytoma and Thyroid Tumors (Multi-H... [Phase 2]

View source ↗

Summary

Phase II, multi-histology trial of fostamatinib disodium (R935788) in advanced colorectal, non-small cell lung, head and neck, hepatocellular, and renal cell ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Head and Neck Cancer
• Hepatocellular Carcinoma
• Non-small Cell Lung Cancer
• Pheochromocytoma
• Renal Cell Carcinoma
• Thyroid Cancer

Drugs mentioned

• Fostamatinib disodium (R935788) (fostamatinib disodium)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Head and Neck Neoplasms, Pheochromocytoma | Phase 2 | Status: COMPLETED | Results posted: 2012-08-29